Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions. 

The study's authors examined data from multiple bioprosthetic aortic valves — and one popular solution consistently came out on top. 

The new analysis focused on both primary and secondary MR 12 months after TEER. 

Researchers highlighted the low risk of reintervention after the Ross procedure, though they did say additional studies were still needed. 

Researchers reviewed data from more than 900 patients, sharing their research in the American Journal of Cardiology.

Bioprosthetic heart valves often express foreign sugars that trigger a response from the body's immune system. This immune response appears to be associated with calcification. 

Researchers developed the new algorithm by identifying eight key factors associated with mortality among TEER patients. 

Researchers focused on 30-day outcomes, sharing their findings in the American Journal of Cardiology.